New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel 'Neoantigen'

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells.